DiaMedica Therapeutics Inc.
DMAC
$6.59
$0.050.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.95M | 9.79M | 9.78M | 9.22M | 8.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.23M | 36.74M | 34.40M | 33.60M | 31.45M |
| Operating Income | -39.23M | -36.74M | -34.40M | -33.60M | -31.45M |
| Income Before Tax | -37.51M | -35.07M | -32.74M | -31.90M | -29.55M |
| Income Tax Expenses | 30.00K | 29.00K | 28.00K | 27.00K | 28.00K |
| Earnings from Continuing Operations | -37.54 | -35.10 | -32.77 | -31.93 | -29.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.54M | -35.10M | -32.77M | -31.93M | -29.58M |
| EBIT | -39.23M | -36.74M | -34.40M | -33.60M | -31.45M |
| EBITDA | -39.17M | -36.69M | -34.35M | -33.56M | -31.42M |
| EPS Basic | -0.72 | -0.71 | -0.70 | -0.72 | -0.69 |
| Normalized Basic EPS | -0.45 | -0.44 | -0.44 | -0.45 | -0.43 |
| EPS Diluted | -0.72 | -0.71 | -0.70 | -0.72 | -0.69 |
| Normalized Diluted EPS | -0.45 | -0.44 | -0.44 | -0.45 | -0.43 |
| Average Basic Shares Outstanding | 209.73M | 198.80M | 187.85M | 178.24M | 171.36M |
| Average Diluted Shares Outstanding | 209.73M | 198.80M | 187.85M | 178.24M | 171.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |